Bharati R Dhruva
Examiner (ID: 3913)
Most Active Art Unit | 1632 |
Art Unit(s) | 1632 |
Total Applications | 2 |
Issued Applications | 1 |
Pending Applications | 1 |
Abandoned Applications | 0 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 17561800
[patent_doc_number] => 20220125949
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-28
[patent_title] => GENE THERAPY FOR TREATING MUCOPOLYSACCHARIDOSIS TYPE II
[patent_app_type] => utility
[patent_app_number] => 17/573883
[patent_app_country] => US
[patent_app_date] => 2022-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 47047
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 113
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17573883
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/573883 | GENE THERAPY FOR TREATING MUCOPOLYSACCHARIDOSIS TYPE II | Jan 11, 2022 | Pending |
Array
(
[id] => 18517657
[patent_doc_number] => 11707528
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-07-25
[patent_title] => Mannose-based mRNA targeted delivery system and use thereof
[patent_app_type] => utility
[patent_app_number] => 17/559620
[patent_app_country] => US
[patent_app_date] => 2021-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 14
[patent_no_of_words] => 5862
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17559620
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/559620 | Mannose-based mRNA targeted delivery system and use thereof | Dec 21, 2021 | Issued |
Array
(
[id] => 18574319
[patent_doc_number] => 11730825
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-08-22
[patent_title] => Lipid nanoparticle compositions and methods for mRNA delivery
[patent_app_type] => utility
[patent_app_number] => 17/558310
[patent_app_country] => US
[patent_app_date] => 2021-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 17976
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17558310
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/558310 | Lipid nanoparticle compositions and methods for mRNA delivery | Dec 20, 2021 | Issued |
Array
(
[id] => 18116392
[patent_doc_number] => 11547764
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-01-10
[patent_title] => Lipid nanoparticle compositions and methods for MRNA delivery
[patent_app_type] => utility
[patent_app_number] => 17/556573
[patent_app_country] => US
[patent_app_date] => 2021-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 17978
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 129
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17556573
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/556573 | Lipid nanoparticle compositions and methods for MRNA delivery | Dec 19, 2021 | Issued |
Array
(
[id] => 17532462
[patent_doc_number] => 20220111071
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-14
[patent_title] => LIPID NANOPARTICLE COMPOSITIONS AND METHODS FOR MRNA DELIVERY
[patent_app_type] => utility
[patent_app_number] => 17/556978
[patent_app_country] => US
[patent_app_date] => 2021-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17921
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17556978
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/556978 | LIPID NANOPARTICLE COMPOSITIONS AND METHODS FOR MRNA DELIVERY | Dec 19, 2021 | Abandoned |
Array
(
[id] => 17807733
[patent_doc_number] => 20220259568
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-18
[patent_title] => COMPOSITIONS AND METHODS FOR ENHANCED GENE EXPRESSION IN CONE CELLS
[patent_app_type] => utility
[patent_app_number] => 17/556847
[patent_app_country] => US
[patent_app_date] => 2021-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29178
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17556847
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/556847 | COMPOSITIONS AND METHODS FOR ENHANCED GENE EXPRESSION IN CONE CELLS | Dec 19, 2021 | Pending |
Array
(
[id] => 17619017
[patent_doc_number] => 11338044
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-05-24
[patent_title] => Lipid nanoparticle compositions and methods for mRNA delivery
[patent_app_type] => utility
[patent_app_number] => 17/556974
[patent_app_country] => US
[patent_app_date] => 2021-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 17939
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 153
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17556974
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/556974 | Lipid nanoparticle compositions and methods for mRNA delivery | Dec 19, 2021 | Issued |
Array
(
[id] => 17655499
[patent_doc_number] => 20220175964
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-09
[patent_title] => DYSTROPHIN R16/R17 SYNTROPHIN PDZ FUSION PROTEINS
[patent_app_type] => utility
[patent_app_number] => 17/555233
[patent_app_country] => US
[patent_app_date] => 2021-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21313
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17555233
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/555233 | DYSTROPHIN R16/R17 SYNTROPHIN PDZ FUSION PROTEINS | Dec 16, 2021 | Pending |
Array
(
[id] => 17695935
[patent_doc_number] => 11369637
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-06-28
[patent_title] => Restimulation of cryopreserved tumor infiltrating lymphocytes
[patent_app_type] => utility
[patent_app_number] => 17/548504
[patent_app_country] => US
[patent_app_date] => 2021-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 41923
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 194
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17548504
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/548504 | Restimulation of cryopreserved tumor infiltrating lymphocytes | Dec 10, 2021 | Issued |
Array
(
[id] => 17503453
[patent_doc_number] => 20220096555
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-31
[patent_title] => RESTIMULATION OF CRYOPRESERVED TUMOR INFILTRATING LYMPHOCYTES
[patent_app_type] => utility
[patent_app_number] => 17/548502
[patent_app_country] => US
[patent_app_date] => 2021-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41914
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 204
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17548502
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/548502 | Restimulation of cryopreserved tumor infiltrating lymphocytes | Dec 10, 2021 | Issued |
Array
(
[id] => 17648498
[patent_doc_number] => 11351199
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-06-07
[patent_title] => Restimulation of cryopreserved tumor infiltrating lymphocytes
[patent_app_type] => utility
[patent_app_number] => 17/547192
[patent_app_country] => US
[patent_app_date] => 2021-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 41899
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 179
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17547192
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/547192 | Restimulation of cryopreserved tumor infiltrating lymphocytes | Dec 8, 2021 | Issued |
Array
(
[id] => 17482635
[patent_doc_number] => 20220090139
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-24
[patent_title] => DESIGN OF BACTERIOPHAGE-BASED ARTIFICIAL VIRUSES FOR HUMAN GENOME REMODELING
[patent_app_type] => utility
[patent_app_number] => 17/546183
[patent_app_country] => US
[patent_app_date] => 2021-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20992
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17546183
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/546183 | DESIGN OF BACTERIOPHAGE-BASED ARTIFICIAL VIRUSES FOR HUMAN GENOME REMODELING | Dec 8, 2021 | Pending |
Array
(
[id] => 17480576
[patent_doc_number] => 20220088080
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-24
[patent_title] => RESTIMULATION OF CRYOPRESERVED TUMOR INFILTRATING LYMPHOCYTES
[patent_app_type] => utility
[patent_app_number] => 17/547190
[patent_app_country] => US
[patent_app_date] => 2021-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41899
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 189
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17547190
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/547190 | Restimulation of cryopreserved tumor infiltrating lymphocytes | Dec 8, 2021 | Issued |
Array
(
[id] => 17443718
[patent_doc_number] => 20220064223
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-03
[patent_title] => BRANCHED RECEPTOR BINDING MULTI-SUBUNIT PROTEIN COMPLEXES FOR USE IN BACTERIAL DELIVERY VEHICLES
[patent_app_type] => utility
[patent_app_number] => 17/527766
[patent_app_country] => US
[patent_app_date] => 2021-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32030
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17527766
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/527766 | BRANCHED RECEPTOR BINDING MULTI-SUBUNIT PROTEIN COMPLEXES FOR USE IN BACTERIAL DELIVERY VEHICLES | Nov 15, 2021 | Pending |
Array
(
[id] => 18028943
[patent_doc_number] => 11512116
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-11-29
[patent_title] => Chimeric receptor binding proteins for use in bacterial delivery vehicles
[patent_app_type] => utility
[patent_app_number] => 17/527754
[patent_app_country] => US
[patent_app_date] => 2021-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 31250
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 232
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17527754
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/527754 | Chimeric receptor binding proteins for use in bacterial delivery vehicles | Nov 15, 2021 | Issued |
Array
(
[id] => 18004985
[patent_doc_number] => 20220363751
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-17
[patent_title] => IMMUNOLOGIC EFFECTOR CELL OF TARGETED CLD18A2, AND PREPARATION METHOD AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/522284
[patent_app_country] => US
[patent_app_date] => 2021-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8412
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17522284
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/522284 | IMMUNOLOGIC EFFECTOR CELL OF TARGETED CLD18A2, AND PREPARATION METHOD AND USE THEREOF | Nov 8, 2021 | Pending |
Array
(
[id] => 17512614
[patent_doc_number] => 11291734
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-04-05
[patent_title] => Lipid nanoparticle compositions and methods for mRNA delivery
[patent_app_type] => utility
[patent_app_number] => 17/509674
[patent_app_country] => US
[patent_app_date] => 2021-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 17950
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17509674
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/509674 | Lipid nanoparticle compositions and methods for mRNA delivery | Oct 24, 2021 | Issued |
Array
(
[id] => 17875768
[patent_doc_number] => 11447771
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2022-09-20
[patent_title] => CRISPR DNA targeting enzymes and systems
[patent_app_type] => utility
[patent_app_number] => 17/506627
[patent_app_country] => US
[patent_app_date] => 2021-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 50
[patent_figures_cnt] => 50
[patent_no_of_words] => 24535
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 106
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17506627
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/506627 | CRISPR DNA targeting enzymes and systems | Oct 19, 2021 | Issued |
Array
(
[id] => 17836513
[patent_doc_number] => 20220273818
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-01
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING CEP290-ASSOCIATED DISEASE
[patent_app_type] => utility
[patent_app_number] => 17/450544
[patent_app_country] => US
[patent_app_date] => 2021-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 111966
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17450544
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/450544 | COMPOSITIONS AND METHODS FOR TREATING CEP290-ASSOCIATED DISEASE | Oct 10, 2021 | Pending |
Array
(
[id] => 17344004
[patent_doc_number] => 20220010335
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-13
[patent_title] => PROKARYOTIC-EUKARYOTIC HYBRID VIRAL VECTOR FOR DELIVERY OF LARGE CARGOS OF GENES AND PROTEINS INTO HUMAN CELLS
[patent_app_type] => utility
[patent_app_number] => 17/488542
[patent_app_country] => US
[patent_app_date] => 2021-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13306
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -1
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17488542
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/488542 | Prokaryotic-eukaryotic hybrid viral vector for delivery of large cargos of genes and proteins into human cells | Sep 28, 2021 | Issued |